Back to TWO SIGMA INVESTMENTS, LP TWO SIGMA INVESTMENTS, LP

JANXJANX
Showing 8 of 12 quarters

Position history for TWO SIGMA INVESTMENTS, LPTWO SIGMA INVESTMENTS, LP's holdings in JANUX THERAPEUTICS INC

Yes. Two Sigma holds 1,207,250 shares of JANX (Janux Therapeutics), worth $18.5M, as of its Q2 2026 13F filing. It increased the position from 116,099 shares in Q1 2026. Two Sigma has held JANX since Q2 2025, across 5 quarterly 13F filings.

Current Value

$18.5M

Current Shares

1.2M

Total Value Change

+$15M

Total Shares Change

+1.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.2M
+939.9%
$18.5M0.0%$15.36
46
2026-Q1
Decreased
116,099
-75.3%
$1.6M0.0%$13.44
0
2025-Q4
Increased
471,009
+355.2%
$6.5M0.0%$13.83
44
2025-Q3
Decreased
103,476
-0.9%
$2.5M0.0%$23.70
0
2025-Q2
New
104,382
-
$2.4M0.0%$23.15
36
2025-Q1
Exited
0
-100.0%
$00.0%$29.10
0
2024-Q4
Decreased
59,974
-22.3%
$3.2M0.0%$52.50
0
2024-Q3
Decreased
77,192
-25.5%
$3.5M0.0%$46.25
0

Other major holders of JANX: RA CAPITAL MANAGEMENT, L.P., FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used